Targed Biopharmaceuticals Picks Up Series A
Targed Biopharmaceuticals Picks Up Series A
02/22/22, 3:46 PM
TargED Biopharmaceuticals, a developer of treatments for thrombotic diseases, has raised 39 million euros in Series A financing.
Company Info
Targ Ed Biopharmaceuticals